"The results of the trial conducted by NYU Langone, with TRP’s CBD
ingredient, are very encouraging and I’m eager to see the results of the next round.”
- President William J Clinton
“I am excited by TRP’s focus on responsible development of cannabinoids and believe
patients, physicians, and pharmaceutical companies are looking for safe and effective
solutions for pain management and general health and well-being.”
- Dr. Andrea G Barthwell
TRP Board Member & Former Deputy Director for Demand Reduction at The Office of National Drug Control Policy
Follow Our Journey
Transforming health and well-being through science.